e-learning
resources
ERJ
2017
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
A longitudinal modelling study estimates acute symptoms of community acquired pneumonia recover to baseline by 10 days
Daniel G. Wootton, Laura Dickinson, Henry Pertinez, Joanne Court, Odiri Eneje, Lynne Keogan, Laura Macfarlane, Sarah Wilks, Jane Gallagher, Mark Woodhead, Stephen B. Gordon, Peter J. Diggle
Source:
Eur Respir J, 49 (6) 1602170; 10.1183/13993003.02170-2016
Journal Issue:
June
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Daniel G. Wootton, Laura Dickinson, Henry Pertinez, Joanne Court, Odiri Eneje, Lynne Keogan, Laura Macfarlane, Sarah Wilks, Jane Gallagher, Mark Woodhead, Stephen B. Gordon, Peter J. Diggle. A longitudinal modelling study estimates acute symptoms of community acquired pneumonia recover to baseline by 10 days. Eur Respir J, 49 (6) 1602170; 10.1183/13993003.02170-2016
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
An RDW-based score predicts mid-term mortality in patients hospitalized with community acquired pneumonia (CAP): a derivation and validation study
Source: International Congress 2019 – Prognosis in bacterial and viral pneumonia
Year: 2019
To establish the characteristics which influence patients with an acute exacerbation of COPD to die within 2 weeks of hospital admission compared to those after a 2-week period
Source: Eur Respir J 2005; 26: Suppl. 49, 283s
Year: 2005
An RDW-based clinical model predicts long-term survival in patients hospitalized with community acquired pneumonia (CAP): a derivation and validation multicentric study
Source: Virtual Congress 2020 – Lower respiratory tract infections in clinical practice
Year: 2020
A clinical and outcomes assessment of the management of acute episodes of chronic bronchitis (AECB) : the MOSAIC study - baseline characteristics of screened patients
Source: Eur Respir J 2002; 20: Suppl. 38, 544s
Year: 2002
Comparison of prospective scores for predicting mortality and hospital admission in hospitalised patients and out-patients with CAP
Source: Annual Congress 2005 - Community-acquired pneumonia: clinical approaches
Year: 2005
A delay in reaching time to clinical stability (tcs) for hospitalized patients with community-acquired pneumonia (CAP) is associated with failure within 30 days after hospital discharge
Source: Annual Congress 2009 - Ventilator-associated pneumonia, severe community-acquired pneumonia and healthcare associated pneumonia
Year: 2009
Prevalence of heart disease in patients hospitalized for an acute exacerbation of COPD: Impact on clinical outcome. A 6 month follow-up study
Source: Annual Congress 2011 - COPD management
Year: 2011
Cardiopulmonary exercise testing to assess persistent symptoms at 6 months in people with COVID-19 who survived hospitalisation – A pilot study.
Source: Virtual Congress 2021 – Assessing the impact of COVID-19 on lung function
Year: 2021
Different factors have impact on severe pneumonia resolution and mortality after the initial treatment period
Source: Eur Respir J 2003; 22: Suppl. 45, 150s
Year: 2003
Defining prognostic factors in the elderly with community acquired pneumonia: a case controlled study of patients aged >=75 yrs
Source: Eur Respir J 2001; 17: 200-205
Year: 2001
Incidence of COPD in a sample of patients with psychosis: preliminary data from a 10 years longitudinal study
Source: International Congress 2019 – Phenotypes and comorbidities of airway diseases
Year: 2019
A prospective comparison of nursing home acquired pneumonia with community acquired pneumonia
Source: Eur Respir J 2001; 18: 362-368
Year: 2001
Are patients who report persistent symptoms and days lost due to asthma more likely to be hospitalised in the subsequent year?
Source: Eur Respir J 2002; 20: Suppl. 38, 204s
Year: 2002
Effect on outcome of antibiotic treatment during the 2 weeks before hospital admission for community acquired pneumonia
Source: Annual Congress 2010 - Aetiology of lower respiratory tract infections and treatment in special situations
Year: 2010
The general evaluation of community acquired pneumonia patients treated in our clinic
Source: Eur Respir J 2004; 24: Suppl. 48, 414s
Year: 2004
The ARIETTA study: baseline demographics in a real-world setting in patients with severe asthma
Source: International Congress 2017 – Bronchial asthma management
Year: 2017
Clinical profile and outcomes of patients with moderate and high risk community acquired pneumonia with mixed pathogens
Source: Annual Congress 2007 - Community-acquired pneumonia: from aetiology to complication
Year: 2007
Clinical failure in hospitalized patients with community acquired pneumonia (CAP): Preliminary results from the FAILCAP study
Source: Annual Congress 2011 - Assessment of severity and predictors of outcomes in community-acquired pneumonia
Year: 2011
A new treatment algorithm for acute exacerbation of IPF: a retrospective cohort study.
Source: International Congress 2019 – Recent developments in intensive care unit medicine
Year: 2019
An analysis of clinical features of hospitalized asthmatic children over a 5-year period: a single center experience
Source: International Congress 2017 – Diagnostic tools in paediatric asthma
Year: 2017
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept